For adults with diabetes and obesity, GLP-1 RAs are associated with a reduced risk for obesity-related cancer compared with DPP-4 inhibitors.

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...

Multitarget stool DNA testing in a primary care setting yielded a low colorectal cancer detection rate and a high false negative rate.

An estimated 5.17% of patients with inflammatory bowel diseases also have bronchiectasis, as shown in chest CT scans of patients with IBD.

The global incidence of adverse events during colonoscopy is low; however, risks such as perforation and bleeding still occur at consistent rates.

The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.

Alcohol-associated cancer mortality in the United States increased from 1990 to 2021, according to a recent study.

Treatment with retifanlimab plus carboplatin-paclitaxel statistically significantly reduced the risk of progression or death by 37% compared with placebo plus carboplatin-paclitaxel.

The average annual national percentage change in mortality from hepatocellular carcinoma from 2005 to 2023 was higher for rural vs urban residents.

HealthDay News — Nebraska is the first state to get federal approval to ban the purchase of soda and energy drinks under the Supplemental Nutrition Assistance Program (SNAP), also known as food stamps ...

In patients with Barrett esophagus, EAC significantly increased all-cause mortality, but rates remained elevated after excluding EAC-related deaths.

Most top-selling liver supplements on Amazon lack strong scientific evidence for safety or efficacy, with many relying on limited research.